Technology-assisted adaptive recruitment strategy for a large nation-wide COVID-19 vaccine immunogenicity study in Brunei

• Egile Nagusiak: Chin Yee Shim (Egilea), Si Yee Chan (Egilea), Yuan Wei (Egilea), Hazim Ghani (Egilea), Liyana Ahmad (Egilea), Hanisah Sharif (Egilea), Mohammad Fathi Alikhan (Egilea), Saifuddien Haji Bagol (Egilea), Surita Taib (Egilea), Chee Wah Tan (Egilea), Xin Mei Ong (Egilea), Lin-Fa Wang (Egilea), Yan Wang (Egilea), An Qi Liu (Egilea), Hong Shen Lim (Egilea), Justin Wong (Egilea), Lin Naing (Egilea), Anne Catherine Cunningham (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

A national study was conducted in Brunei to assess and compare the immunogenicity of the various brands of COVID-19 vaccines administered to the population as part of the National COVID-19 Vaccination Programme. Most of the population have had received at least 2 doses of BBIBP-CorV, AZD1222 or MRNA...